Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway

The usefulness of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a risk marker of coronary heart disease in the general population remains unclear. In a nested case-control study in Norway, 1,488 incident myocardial infarctions were registered during 11.3 years of follow-up and...

Descripción completa

Detalles Bibliográficos
Autores principales: Laugsand, Lars E., Åsvold, Bjørn O., Vatten, Lars J., Janszky, Imre, Platou, Carl G., Michelsen, Annika E., Damås, Jan K., Aukrust, Pål, Ueland, Thor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113535/
https://www.ncbi.nlm.nih.gov/pubmed/30167541
http://dx.doi.org/10.1016/j.jacbts.2016.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113535/
https://www.ncbi.nlm.nih.gov/pubmed/30167541
http://dx.doi.org/10.1016/j.jacbts.2016.06.007

Ejemplares similares